Global Barbiturate Drugs Market Size (2024 - 2029)

Barbiturate Drugs Market Analysis

The barbiturate drug market is expected to register a CAGR of 3.7% over the forecast period, 2022-2027.

The COVID-19 pandemic has created exceptional changes in the lives of the people. For many, it has caused significant stress, anxiety, sleep disorder, and concerns about health, social isolation, employment, finances, and the challenge of balancing work and family obligations. Such a significant life event is likely to disrupt sleep and has an impact on market growth. The COVID-19 pandemic has impacted sleep. According to the American Academy of Sleep Medicine's (AASM) Sleep Prioritization Survey 2020, about a third of adults (33%) have noticed a change in their sleep quality, 30% have noticed a change in their ability to fall asleep, and 29% have noticed a change in their nightly amount of sleep. In addition, females were more likely to report that bedtimes (31%) are impacted by the COVID-19 pandemic than males (25%).

The rise in prevalence of insomnia, epilepsy, and anxiety and the increase in the geriatric population are projected to drive the global barbiturate drug market during the forecast period. For instance, according to the World Health Organization facts of 2022, epilepsy is one of the most common neurological diseases globally and affects about 50 million people worldwide. In high-income countries, about 49 per 100000 people are usually diagnosed with epilepsy each year, and in low- and middle-income countries, this figure can be as high as 139 per 100 000. 

However, side effects associated with barbiturate drugs and patient expiration are expected to restrain the barbiturate drugs market over the forecast period.

Barbiturate Drugs Industry Segmentation

Barbiturates are a group of sedative-hypnotic medications used for the treatment of seizure disorder, neonatal withdrawal, insomnia, preoperative anxiety, and induction of coma for increased intracranial pressure. They are also useful for inducing anesthesia. The Barbiturate Drugs Market is segmented by Drug Type (Ultra-Short Acting Barbiturate, Short-Acting Barbiturate, Long-Acting Barbiturate, and Combination Drugs), Disease Type (Epilepsy, Insomnia, Sedation, and Other Disease Type), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Other Pharmacies), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The report offers the value (in USD million) for the above-mentioned segments.